NEW YORK (AP) — A Goldman Sachs analyst said Tuesday that Express Scripts Holding Co. is poised for strong profit growth for the rest of this decade after the pharmacy benefits manager completed its acquisition of former competitor Medco Health Solutions.

THE OPINION: Analyst Robert Jones said the $29.1 billion deal makes Express Scripts a "dominant" company in health care. He said the St. Louis company's per-share profit should grow more than 20 percent per year through 2015 and should rise by at least 10 percent per year through 2020.

Jones resumed coverage of Express Scripts stock with a "Buy" rating and placed the stock on the Conviction List, a portfolio of highly recommended stocks. Jones also set a price target of $70 per share.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.